Clinical Trials Directory

Trials / Completed

CompletedNCT02247388

Automated Bilingual Computerized Alcohol Screening and Intervention in Latinos (AB-CASI)

Automated Bilingual Computerized Alcohol Screen and Intervention in Latinos

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
840 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To study the efficacy of AB-CASI against standard of care in a randomized controlled trial in the Emergency Department.

Detailed description

The research team will rigorously test the efficacy of AB-CASI, against a standard condition (SC) in a first-of-a-kind ED randomized controlled trial. Studying an urban adult (≥ 18 y/o) Latino ED population, the objectives are to demonstrate the superiority of AB-CASI compared to SC in: 1) reduction of alcohol consumption (Aims 1), 2) reduction of negative health behaviors and consequences (Aim 2), and 3) increasing 30-day treatment engagement (Aim 3). The investigators will also explore variation of the AB-CASI intervention on alcohol consumption, alcohol-related negative health behaviors and consequences, and 30-day treatment engagement by Latino subpopulations (Puerto-Rican, Mexican-American, Cuban-American, South/Central American) as well as other potential modifiers (age, birthplace, gender, preferred language, reason for ED visit, and smoking status). English and Spanish speaking Latino adults presenting to the Bridgeport Hospital ED will be screened using the study inclusion and exclusion criteria. In March 2020, the primary and secondary outcomes were corrected to reflect the protocol as it was written initially. The citations section of this study registration also includes the citation for the published protocol manuscript.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComputerized Alcohol ScreeningiPad based automated alcohol screening
BEHAVIORALBrief Negotiated InterviewiPad based automated brief negotiated interview (BNI)

Timeline

Start date
2014-10-01
Primary completion
2020-04-30
Completion
2020-04-30
First posted
2014-09-25
Last updated
2022-04-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02247388. Inclusion in this directory is not an endorsement.